
|Articles|January 31, 2022
DFE Pharma offers starch-based excipients for nutraceuticals
Author(s)Jennifer Grebow
The excipients are naturally sourced and multifunctional as binders, fillers, and disintegrants for oral solid dosage forms.
Advertisement
DFE Pharma (Goch, Germany) has launched its Nutroféli line of starch-based excipients for nutraceuticals. The excipients are naturally sourced and multifunctional as binders, fillers, and disintegrants for oral solid dosage forms.
The Nutroféli line includes a native starch excipient (Nutroféli ST100), a partially pregelatinized starch (Nutroféli ST200), and a fully gelatinized starch (Nutroféli ST300).
The starches comply with clean-label requirements and both food and pharmaceutical monographs, the company says.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Thorne Prenatal Supplement Earns NSF Certified for Sport Certification
2
RFI Ingredients Takes On Minority Investment From Astanor to Fund Global Expansion
3
OmniActive Launches Fenavari, a Combined Fenugreek-Shatavari Ingredient for Menopause Support
4
Solaray Launches UNLIMIT Line Anchored by Creatine, NMN, and Liposomal NAD+
5





